Affinity Biosensors Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.73M
- Investors
-
4
Affinity Biosensors General Information
Description
Developer of an antimicrobial susceptibility testing device designed to provide a rapid way to measure and observe growth and response. The company's device can be used for cell counting, and visual observation of liquid samples, helping healthcare professionals in the measurement of mass in fluid, with femtogram resolution, and detecting positive growth.
Contact Information
Website
www.affinitybio.comCorporate Office
- 222 East Canon Perdido Street
- Suite 101
- Santa Barbara, CA 93101
- United States
Corporate Office
- 222 East Canon Perdido Street
- Suite 101
- Santa Barbara, CA 93101
- United States
Affinity Biosensors Timeline
Affinity Biosensors Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Later Stage VC | 11-Jun-2024 | $3.73M | 000.00 | Completed | Generating Revenue | |
11. Later Stage VC (Series A) | 22-Mar-2024 | 00.00 | 000.00 | Completed | Generating Revenue | |
10. Later Stage VC (Series A) | 17-Nov-2021 | 00.00 | 0000 | Completed | Generating Revenue | |
9. Later Stage VC (Series A3) | 03-Feb-2020 | 00.000 | 000.00 | Completed | Generating Revenue | |
8. Later Stage VC (Series A2) | 17-Dec-2018 | 00.000 | 000.00 | Completed | Generating Revenue | |
7. Later Stage VC (Series A2) | 23-Aug-2016 | 00.000 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC (Series A2) | 09-Feb-2015 | 0000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC (Series B) | 23-Dec-2013 | 00.000 | 00.000 | Completed | Generating Revenue | |
4. Later Stage VC | 19-Jul-2011 | $1.52M | $1.82M | Completed | Generating Revenue | |
3. Grant | 01-Jan-2009 | $899K | $300K | Completed | Generating Revenue |
Affinity Biosensors Comparisons
Industry
Financing
Details
Affinity Biosensors Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Reichert | Formerly PE-Backed | Depew, NY | 000 | 000000&0 | ||
Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | 00 | 000000000000 | ||
Dynamic Biosensors | Venture Capital-Backed | Munich, Germany | 00 | 000.00 | 000000000000 | 000.00 |
Affinity Biosensors Patents
Affinity Biosensors Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9835614-B2 | Measurement of cell growth and drug susceptibility by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | 0 |
US-20150072373-A1 | Measurement of cell growth and drug susceptibility by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | 0 |
EP-3044566-A2 | Measurement of cell growth and drug susceptiblity by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
EP-3044566-B1 | Measurement of cell growth and drug susceptiblity by resonant mass measurement | Active | 09-Sep-2013 | 00000000000 | |
US-20140345369-A1 | System and method for measuring viscosity using particle transit time in resonant microfluidic channels | Inactive | 01-May-2013 | G01N11/10 | 0 |
Affinity Biosensors Executive Team (5)
Name | Title | Board Seat |
---|---|---|
Kenneth Babcock Ph.D | Co-Founder, Chief Executive Officer, Manager and Board Member | |
Steve Markakis | Chief Operating Officer | |
John Foster | Co-Founder | |
Scott Manalis Ph.D | Co-Founder | |
L. Robert Johnson | Manager & Board Member |
Affinity Biosensors Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
James Iuliano | Affinity Biosensors | Board Member | 000 0000 |
L. Robert Johnson | Affinity Biosensors | Manager & Board Member | 000 0000 |
Affinity Biosensors Signals
Affinity Biosensors Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Rose Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Founders Capital Partners | Angel Group | Minority | 000 0000 | 000000 0 |
National Institute of Standards and Technology | Government | 000 0000 | 000000 0 | |
National Science Foundation | Government | 000 0000 | 000000 0 |
Affinity Biosensors Investments (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Travera | 16-Jun-2018 | 00000 0000 | 00.000 | Biotechnology | |
Travera | 20-Feb-2018 | Early Stage VC | 00000 | Biotechnology |
Affinity Biosensors FAQs
-
When was Affinity Biosensors founded?
Affinity Biosensors was founded in 2006.
-
Who is the founder of Affinity Biosensors?
John Foster and Scott Manalis Ph.D are the founders of Affinity Biosensors.
-
Who is the CEO of Affinity Biosensors?
Kenneth Babcock Ph.D is the CEO of Affinity Biosensors.
-
Where is Affinity Biosensors headquartered?
Affinity Biosensors is headquartered in Santa Barbara, CA.
-
What is the size of Affinity Biosensors?
Affinity Biosensors has 25 total employees.
-
What industry is Affinity Biosensors in?
Affinity Biosensors’s primary industry is Diagnostic Equipment.
-
Is Affinity Biosensors a private or public company?
Affinity Biosensors is a Private company.
-
What is Affinity Biosensors’s current revenue?
The current revenue for Affinity Biosensors is 000000.
-
How much funding has Affinity Biosensors raised over time?
Affinity Biosensors has raised $70.2M.
-
Who are Affinity Biosensors’s investors?
Rose Ventures, Founders Capital Partners, National Institute of Standards and Technology, and National Science Foundation have invested in Affinity Biosensors.
-
Who are Affinity Biosensors’s competitors?
Reichert, Nanion Technologies, and Dynamic Biosensors are competitors of Affinity Biosensors.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »